PIMIVALIMAB
UNII MA05AF40UO

Substance Identification & Data

This profile provides standardized clinical and technical data for Pimivalimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) MA05AF40UO.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2293951-22-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

MA05AF40UO

CAS Registry Number

2293951-22-9

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

PIMIVALIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C157485

National Cancer Institute reference terminology for clinical and research data.

INN ID

11461

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

JK-140

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Pimivalimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

PIMIVALIMAB

Common Names & Synonyms

IMMUNOGLOBULIN G4 (226-PROLINE,C-TERMINAL-LYSINE-CLIPPED), ANTI-(HUMAN PROGRAMMED CELL DEATH PROTEIN 1) (HUMAN MONOCLONAL JTX-4014 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN MONOCLONAL JTX-4014 .KAPPA.-CHAIN, DIMER

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS PROGRAMMED CELL DEATH 1 LIGAND 1 (PD-L1; CD274 ANTIGEN)); HUMAN MONOCLONAL ANTIBODY; .GAMMA.4 HEAVY CHAIN HOMO SAPIENS (1-444) (VH HOMO SAPIENS (IGHV1-46*01 (97%) (IGHD)-IGHJ5*02) (8.8.11) (1-118)-HOMO SAPIENS IGHG4*01 ((HINGE(S10>P(226)), CH3(K107>DEL(445))) (119-444)) (132-214')-DISULFIDE WITH .KAPPA. LIGHT CHAIN HOMO SAPIENS (1'-214') (V-KAPPA (HOMO SAPIENS IGKV1-5*01 (98%) IGKJ4*01)(6.3.9) (1'-107')-HOMO SAPIENS IGKC*01 (108'-214')), DIMER (224-224'':227-227'')-BISDISULFIDE, PRODUCED IN CHO CELL, GLYCOFORM ALFA

PIMIVALIMAB [INN]

PIMIVALIMAB [USAN]

PIMIVALIMAB [WHO-DD]